medigraphic.com
A partir del año 2010, la Revista Oficial del INER cambió a NCT (Neumología y Cirugía de Tórax)

 Ver actualización

2004, Number 4

<< Back Next >>

Rev Inst Nal Enf Resp Mex 2004; 17 (4)

Monographic perspective of lung cancer: A molecular focus and brain metastasis.

Mayoral-Chávez MA, Zenteno GE, Espinosa MB, Martínez CS, Guevara FJ

Language: Spanish
References: 72
Page: 283-292
PDF size: 194.28 Kb.


ABSTRACT

Cancer is one of the main causes of death in the world. In Mexico, like in developed countries, lung cancer is very frequent and particularly severe when there is metastatic disease. Metastasis: Cell sowing at a distance is the worst complication of cancer. The main cause of death in cancer is metastasis. Cell migration and metastasis are not randomized. There is evidence of cellular tumor predisposition for metastasis; furthermore, the migrating cell does it through the participation of several adhesion molecules, carbohydrate-ligand proteins and related cytokinetics phenomena. When metastatic cells are deposited in the central nervous system, the probabilities for recuperation or survival are nil. Glycosylation: The role of cell-surface oligosaccharides in the recognition, signalization, migration, cell-cell and cell-extracellular matrix interactions, is crucial for the development, proliferation, migration, invasion and eventual metastasis of the neoplastic cell. Modifications in the expression of the cell-surface oligosaccharides have influence in carcinogenesis and metastasis. Conclusions: In this review, we present the evidence supporting the molecular basis of lung carcinogenesis, and the cell migration phenomena which are involved in brain metastasis.


REFERENCES

  1. Medina-Morales F, Salazar-Flores M. Frecuencia y patrón cambiante del cáncer pulmonar en México. Salud Pub Mex 2000;42:333-336.

  2. Medina MF, Salazar FM, García-Sancho MC, Franco MF. Epidemiología descriptiva del cáncer pulmonar en el Instituto Nacional de Enfermedades Respiratorias, México, 1997-2000. Rev Inst Nal Enf Resp Mex 2002;15:149-152.

  3. Franco-Medina F, Villalba-Caloca J. La epidemia de cáncer pulmonar en México. Rev Inst Nal Enf Resp Mex 2001;14:207-214.

  4. Arias AM, Fernández AD, Almunia A, Acosta L, Llana M. Neoplasia de pulmón. Comportamiento epidemiológico. Rev Cubana Oncol 2001;17:101-104.

  5. Abdel-Rahman SZ, El-Zein RA. Association of the NAT1*10 genotype with increased chromosome aberrations and higher lung cancer risk in cigarette smokers. Mutat Res 1998;26:43-54.

  6. Amos CI, Xu W, Spitz MR. Is there a genetic basis for lung cancer susceptibility? Recent Results Cancer Res 1999;151:3-12.

  7. Jones E, Dahm-Vicker M, Simon AK, Green A, Powrie F, Cerundolo V, et al. Depletion of CD25 regulatory cells results in suppression of melanoma growth and induction of autoreactivity in mice. Cancer Imm 2002;2:1-12.

  8. Hainaut P, Pfeifer GP. Patterns of p53 G®T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke. Carcinog 2001;22:367-374.

  9. Djousse´ L, Dorgan JF, Zhang Y, Schatzkin A, Hood M, D’Agostino RB, et al. Alcohol consumption and risk of lung cancer: The Framingham study. J Natl Cancer Inst 2002;94:1877-1882.

  10. Alva LLF, Corcho VA, García-Sancho FC, Salazar FM, Rébora TF, Franco MF, et al. Epidemiología del cáncer pulmonar en México; hallazgos por imagen. Rev Inst Nal Enf Resp Mex 2003;16:197-204.

  11. Gazdar AF. The molecular and cellular basis of human lung cancer. Anticancer Res 1994;14:261-267.

  12. Niklinska W, Chyczewski L, Laudanski J, Sawicki B, Niklinski J. Detection of P53 abnormalities in non-small cell lung cancer by yeast functional assay. Folia Histochem Cytobiol 2001;39:147-148.

  13. Bennett WP, Hussain SP, Vahakangas KH, Khan MA, Shields PG, Harris CC. Molecular epidemiology of human cancer risk: gene-environment interactions and p53 mutation spectrum in human lung cancer. J Pathol 1999;187:8-18.

  14. Hainaut P, Pfeifer GP. Patterns of p53 G®T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke. Carcinogenesis 2001;22:367-374.

  15. Hackshaw AK, Law MR, Wald NJ. The accumulated evidence on lung cancer and environmental tobacco smoke. BMJ 1997;315:980-988.

  16. Tirmarche M. Evaluation du risque de cancer lié à l’inhalation du radon. Rev l’ACOMEN 1998;4:11-18.

  17. Nyberg F, Agrenius V, Svartengren K, Svensson C, Pershagen Gl. Dietary factors and risk of lung cancer in never-smokers. Int J Cancer 1998;78:430-436.

  18. Steenland K, Stayner L. Silica, asbestos, man-made mineral fibers, and cancer. Cancer Causes Control 1997;8:491-503.

  19. Grimsrud TK, Berge SR, Haldorsen T, Andersen A. Exposure to different forms of nickel and risk of lung cancer. Am J Epidem 2002;156:1123-1132.

  20. Cattan KL, Chouaïd C, Monnet I, Atassi K, Bassinet L, Dhissi G, et al. Evaluation des expositions professionnelles et cancer bronchopulmonaire. Rev Mal Respir 2000;17:957-962.

  21. Lam S, leRiche JC, Zheng Y, Coldman A, MacAulay C, Hawk E, et al. Sex-related differences in bronchial epithelial changes associated with tobacco smoking. J Natl Cancer Inst 1999;91:691-696.

  22. Ignacio I, Wistuba MD. Comparison of molecular changes in lung cancers in HIV-Positive and HIV-Indeterminate subjects. JAMA 1998;279:1554-1559.

  23. Abbey DE, Nishino N, McDonell ENF, Burchette RJ, Knutsen SF, Beeson WL, et al. Long-term inhalable particles and other air pollutants related to mortality in nonsmokers. Am J Respir Crit Care Med 1999;159:373-382.

  24. Blot WJ, Fraumeni JF. Lung cancer mortality in the US: Shipyard correlations source. Ann NY Acad Sci 1979;330:313-315.

  25. Martínez-Cayuela M. Xenobiotic toxicity mediated by oxigen free radicals. Ars Pharma 1998;39:5-18.

  26. Harley NH, Harley JH. Potential lung cancer risk from indoor radon exposure. CA Cancer J Clin 1990;40: 265-275.

  27. Kumagai Y, Pi JB, Lee S, Sun GF, Yamanushi T, Sagai M, et al. Serum antioxidants vitamins and risk of lung and stomach cancers in Shenyang. Cancer Lett 1998;129:145-149.

  28. Smith-Warner SA, Ritz J, Hunter DJ, Albanes D, Beeson WL, van den Brandt PA, et al. Dietary fat and risk of lung cancer in a pooled analysis of prospective studies. Cancer Epidem Biom Prev 2002;11:987-992.

  29. Janne PA, Freidlin B, Saxman S, Johnson DH, Livingston RD, Shepherd FA, et al. The survival of patients treated for limited stage small-cell lung cancer in North America has increased during the past 20 years. Proc Am Soc Clin Oncol 2001;20:317a.

  30. Videtic G, Stitt L. Patients who smoke during concurrent chemoradiation (ChT/RT) for limited small-cell lung cancer (SCLC) have decreased survival. Proc Am Soc Clin Oncol 2002;21:295a.

  31. Landis SH, Murria T, Bolden S, Wingo PA. Cancer statistics 1999. CA Cancer J Clin 1999;49:8-31.

  32. Franklin WA. Diagnosis of lung cancer: pathology of invasive and preinvasive neoplasia. Chest 2000;117:80-89.

  33. Kovkarova E, Stefanovski T, Dimov A, Naumovski J. Telomerase in lung cancer diagnostics. Radiol Oncol 2003;37:109-113.

  34. Turner S, Sherratt JA. Intercellular adhesion and cancer invasion: A discrete simulation using the extended potts model. J Theor Biol 2002;216:85-100.

  35. Perumpanani AJ, Simmons DL, Gearin AJH, Miller KM, Ward G, Norbury J, et al. Extracellular matrix-mediated chemotaxis can impede cell migration. Proc R Soc Lond 1998;265:2347-2352.

  36. Couldrey C, Green JE. Metastases: the glycan connection. Breast Cancer Res 2000;2:321-323.

  37. Terranova VP, Hujanen ES, Martin GR. Basement membrane and the invasive activity of metastatic tumor cells. J Nat Cancer Inst 1986;77:311-316.

  38. Hua J, Muschel RJ. Inhibition of matrix metalloproteinase 9 expression by a ribozyme blocks metastasis in a rat sarcoma model system. Cancer Res 1996;56:5279-5284.

  39. Weiss L. Metastatic inefficiency. Adv Cancer Res 1990;54:159-211.

  40. Wong CW, Lee A, Shientag L, Yu J, Dong Y, Kao G, et al. Apoptosis: An early event in metastatic inefficiency. Cancer Res 2001;61:333-338.

  41. Takenaga K, Nakamura Y, Endo H, Sakiyama S. Involvement of S100-related calcium-binding protein pEL98 (or mts1) in cell motility and tumor cell invasion. Jpn J Cancer Res 1994;85:831-839.

  42. Kimura K, Endo Y, Yonemura Y, Heizmann CW, Schafer BW, Watanabe Y, et al. Clinical significance of S100A4 and E-cadherin-related adhesion molecules in non-small cell lung cancer. Int J Oncol 2000;16:1125-1131.

  43. Gongoll S, Peters G, Mengel M, Piso P, Klempnauer J, Kreipe H, et al. Prognostic significance of calcium-binding protein S100A4 in colorectal cancer. Gastroenterology 2002;123:1478-1484.

  44. Nakamura T, Ajiti T, Murao S, Kamigaki T, Maeda S, Ku Y, et al. Prognostic significance of S100A4 expression in gallbladder cancer. Int J Oncol 2002;20:937-941.

  45. Platt-Higgins AM, Renshaw CA, West CR, Wisntanley JH, DeSilva Rudland S, Barraclough R, et al. Comparison of the metastasis-inducing protein S100A4 (p9ka) with other prognostic markers in human breast cancer. Int J Cancer 2000;89:198-208.

  46. Rudland PS, Platt-Higgins A, Renshaw C, West CR, Wisntanley JH, Robetson L, et al. Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer. Cancer Res 2000;60:1595-1603.

  47. Davies M, Harris S, Rudland P, Barraclough R. Expression of the rat, S-100-related, calcium-binding protein gene, p9Ka, in transgenic mice demonstrates different patterns of expression between these two species. DNA Cell Biol 1995;14:825-832.

  48. Kim EJ, Helfman DM. Characterization of the metastasis-associated protein, S100A4. J Biol Chem 2003;278:30063-30073.

  49. Davies MP, Rudland PS, Robertson L, Parry EW, Jolicoeur P, Barraclough R. Expression of the calcium-binding protein S100A4 (p9Ka) in MMTV-neu transgenic mice induces metastasis of mammary tumors. Oncogene 1996;13:1631-1637.

  50. Ford HL, Salim MM, Chakravarty R, Aluiddin V, Zain SB. Expression of Mts1, a metastasis-associated gene, increases motility but not invasion of a non metastatic mouse mammary adenocarcinoma cell line. Oncogene 1995;11:2067-2075.

  51. Ambartsumian N, Klingelhofer J, Grigorian M, Christensen C, Kriajevska M, Tulchinsky E, et al. The metastasis-associated Mts1(S100A4) protein could act as an angiogenic factor. Oncogene 2001;20:4685-4695.

  52. Novitskaya V, Grigorian M, Kriajevska M, Taravykina S, Bronstein I, Berezin V, et al. Oligomeric forms of the metastasis-related Mts1 (S100A4) protein stimulate neuronal differentiation in cultures of rat hippocampal neurons. J Biol Chem 2000;275:41278-41286.

  53. Belot N, Pochet R, Heizmann CW, Kiss R, Decaestecker C. Extracellular S100A4 stimulates the migration rate of astrocytic tumor cells by modifying the organization of their actin cytoskeleton. Biochim Biophys Acta 2002;1600:74-83.

  54. Grigorian M, Andressen S, Tulchinsky E, Kriajevska M, Carlberg C, Kruse C, et al. Tumor suppressor p53 protein is a new target for the metastasis-associated Mts1/S100A4 protein: functional consequences of their interaction. J Biol Chem 2001;276:22699-22708.

  55. Coutinho PM, Henrissat B. Carbohydrate-active enzymes: an integrated database approach. In: Gilbert HJ, Davies G, Henrissat B, Svensson B, editors. Recent advances in carbohydrate bioengineering. Cambridge: The Royal Society of Chemistry;1999. p.3-12.

  56. Dwek RA. Glycobiology: Toward understanding the function of sugars. Chem Rev 1996;96:683-720.

  57. Furmanek A, Hofsteenge J. Protein C-mannosylation: facts and questions. Acta Bioch Pol 2000;47:781-789.

  58. Hofsteenge J, Mueller DR, de Beer T, Loeffler A, Richter WJ, Vliegenthart JFG. New type of linkage between a carbohydrate and a protein: C-glycosylation of a specific tryptophan residue in human RNase Us. Biochem 1994;33:13524- 13530.

  59. Gade G, Kellner R, Rinehart KL, Proefke ML. A tryptophan-substituted member of the AKH/RPCH family isolated from a stick insect corpus cardiacum. Biochem Biophy Res Commun 1992;189:1303-1309.

  60. Krieg J, Gläsner W, Vicenti A, Doucey M-A, Löffler A, Hess D, et al. C- Mannosylation of human Rnase 2 is an intracellular process performed by a variety of cultured cells. J Biol Chem 1997;272:26687-26692.

  61. Espinosa B, Zenteno R, Mena R, Robitaille Y, Zenteno E, Guevara J. O-Glycosylation in sprouting neurons in Alzheimer disease, indicating reactive plasticity. J Neurop Exp Neur 2001;60:441-448.

  62. Sinha D, Chatterjee M, Mandal C. O-acetylated sialic acid-Their detection, biological significance and alteration in diseases. Trends Glycosc Glicotech 2000;12:17-33.

  63. Von der Ohe M, Wheeler SF, Whurer M, Harvey DJ, Liedtke S, Mühlenhoff M, et al. Localization and characterization of polysialic acid-containing N-linked glycans from bovine NCAM. Glycobiol 2002;12:47-63.

  64. Acheson A, Sunshine J, Rutishauser U. NCAM polysialic acid can regulate both Cell-Cell and Cell-Substrate interactions. J Cell Biol 1991;114:143-153.

  65. Von der Ohe M, Wheeler SF, Whurer M, Harvey DJ, Liedtke S, Mühlenhoff M, et al. Localization and characterization of polysialic acid-containing N-linked glycans from bovine NCAM. Glycobiol 2002;12:47-63.

  66. Acheson A, Sunshine J, Rutishauser U. NCAM polysialic acid can regulate both Cell-Cell and Cell-Substrate interactions. J Cell Biol 1991;114:143-153.

  67. Yamamoto H, Saito T, Kaneko Y, Kersey D, Yong V, Bremer EG, et al. a-2,3-Syaliltransferase mRNA and a-2,3-linked glycoprotein sialylation are increased in malignant gliomas. Brain Res 1997;755:175-179.

  68. Yamamoto H, Swoger J, Greene S, Saito T, Hurh J, Sweeley C, et al. b1,6-N-Acetylglucosamine-bearing N-Glycans in human gliomas: Implications for a role in regulating invasivity. Cancer Res 2000;60:134-142.

  69. Shouten LJ, Rutten J, Huveneers HAM, Twijnstra A. Brain metastasis incidence in a cohort of patients with breast cancer, colon, lung and melanoma. Cancer 2002;94:2698-2705.

  70. Laws ER, Thapar K. Brain tumors. CA Cancer J Clin 1993;43:263-271.

  71. Rivera RM, Salazar M. Cáncer pulmonar: Distribución de metástasis de acuerdo al tipo histológico. Estudio de autopsias. Rev Inst Nal Enf Resp Mex 2002;15:84-99.

  72. Zamze S, Harvey DJ, Pesheun P, Mattu TS, Scachner M, Dwek RA, et al. Glycosylation of a CNS-specific extracellular matrix glycoprotein, tenascin-R, is dominated by O-linked sialylated glycans and “brain-type” neuronal N-glycans. Glycobiol 1999;9:827-831.




2020     |     www.medigraphic.com